Navigation Links
Greenway Medical Technologies Assists Capitol Hill With Shaping of The President's Stimulus Package
Date:2/17/2009

CARROLLTON, Ga., Feb. 17 /PRNewswire/ -- Leaders, customers and partners of Greenway Medical Technologies, led by the company's vice president of marketing and government affairs, Justin Barnes, recently returned from Washington, D.C. where they played an important role in assisting the legislation surrounding the healthcare information technology (HIT) portion of the $787 billion stimulus package that has recently been passed into law.

Greenway's leadership during the past decade in the healthcare IT (HIT) and electronic health record (EHR) industry paved the way for the company and its partners to assist lawmakers and staff with shaping the framework for the stimulus package that includes changes to Medicare and Medicaid payments that add up to more than $30 billion in EHR adoption incentives according to the Congressional Budget Office (CBO). This includes a large amount of public policy and investment changes that encourage and reward the adoption and meaningful use of certified EHR technology by hospitals and physician practices in an effort to create a widespread and interoperable healthcare system by which patient health information can be exchanged quickly and securely across a broad spectrum of providers.

Since 2005, Barnes, on behalf of Greenway(R) and the HIMSS Electronic Health Record Association, has testified or addressed members of Congress and the president's administration on 12 occasions, helping to create more effective HIT legislation and regulation, much of which served as the framework for the stimulus package just passed by Congress and signed by President Barack Obama. Barnes also serves as the chairman of the HIMSS EHR Association, which addresses national efforts to create interoperable EHRs in hospital and ambulatory care settings.

"The creation and support of legislation as well as regulation that advances healthcare IT adoption and interoperability is something
'/>"/>

SOURCE Greenway Medical Technologies
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Greenway Medical Technologies Executive Testifies Before Congress
2. Greenway Medical Technologies Announces Record Breaking Quarter
3. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies
4. Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community-Based Health Organizations
5. Greenway Medical Technologies Continues Record Setting Growth
6. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
7. Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase
8. Greenway Medical Technologies Expands Support for Physician Quality Reporting Initiative and Pay for Performance Programs
9. Greenway Medical Technologies Experiences Continued Growth in OB/GYN Marketplace
10. Greenway Medical Technologies Leads Ambulatory Interoperability Exchange
11. Greenway Medical Technologies Growth Continues with Significant Fiscal Year 2008 Gains

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 In response to a pr...afety Now ," an initiative from the U.S. Anti-Do...ouncil for Responsible Nutrition (CRN), the leadin...ement industry, issued the following statement: ,... CEO: ,, "We share the concerns of Travis Tyg...
(Date:12/2/2009)...vanced cases, study finds , , WEDNESDAY,...s, survival rates for advanced lung cancer patient...ew study has found. , Researchers analyzed data...e 4 non-small cell lung cancer (NSCLC) between 199.... National Cancer Institute,s Surveillance, Epidem...
(Date:12/2/2009)...e remains unclear, researchers say , , W...suggests that enzyme replacement therapy can make ...ry disease, a rare illness that affects the kidney... linked to the lack of an enzyme that helps metabo...cause it boosts the risk for a stroke, heart attac...
(Date:12/2/2009)...., Dec. 2 Researchers f...n blood cancer research at the annual American Soc... December 4-8, 2009. ,, Throughout the ASH con... experts, including Chief Medical Officer Barton K...t Services Hildy Dillon, and Vice President, Resea...
(Date:12/2/2009)... federal government ends nine months of obstructio...Newswire-USNewswire/ -- More than 2,300 healthcare...lities across Southern California will soon vote o...ealthcare Workers (NUHW). ,, A majority of the ...but SEIU delayed the election by filing frivolous ...
Breaking Medicine News(10 mins):Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Gains Made in Lung Cancer Survival 2Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2
...N, Feb. 28 Montana Governor Brian Schweitzer (Cha...ryland Governor Martin O,Malley (Vice Chair of the...election of former DGA Chair Gov. Kathleen Sebeliu...e effort to fix it," Governor Schweitzer said. "In...
... CheckOrphan, the leading news site... iWish, which allows people to visually (creative,...ion of these diseases through and image. In additi...n general. , Basel, Switz...
...GAS, NV New research presented at the 2009 Americ...y Day in Las Vegas suggests that elbow ulnar colla...tion in the Major League Baseball (MLB) draft does...es who had undergone UCL reconstruction prior to t...
...atient Communication Service introduces vSling for...n the web. , , LEHI, Utah, Feb. 27 Smile Reminde...communication feature, vSling, at The 144th Chicag... Reminder to show its revenue boosting communicati...
... is one result, and experts urge better awareness ...HealthDay News) -- Snowblowers might make clearing...e them continue to show up in emergency rooms with...n be reconstructed," said Dr. Daniel Master, an or...
...-Vision Stockholders to Vote GOLD , , CINCINNATI,...ces that Glass Lewis & Co., LLC, a leading ind...ecommended that LCA-Vision stockholders vote to re...ent Directors, in the Joffe Group,s consent solici...
Other Medicine News:Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 2Health News:CheckOrphan Launches iWish to Commemorate Rare Disease Day 3Health News:Elbow ligament reconstruction appears not to effect future professional advancement in baseball 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 2Health News:Smile Reminder Showcases Viral Marketing Tool at Chicago Dental Society's Midwinter Meeting 3Health News:Snowblower Hand Injuries Often Extensive, Study Finds 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 2Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 3Health News:Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group 4
(Date:12/2/2009)..., Dec. 2 TeamHealth Teleradiology ...ion,s largest provider of hospital-based clinical ... to provide teleradiology services for two groups ... signed with UpState Carolina Radiology located in...ology to provide services for the following four h...
(Date:12/2/2009)... Sweden, December 2 DermaGen AB - ... wound healing company "Pergamum" -,today announce...from a,clinical Phase I/IIa study. DermaGen AB is ...atment for atopic dermatitis. Atopic dermatitis is...n and the skin,s weakened barrier,function make pa...
(Date:12/2/2009)... Keryx Biopharmaceuticals....S. Food and Drug Administration (FDA) has granted... the Company,s novel, potentially first-in-class, ...ositide 3-kinase (PI3K)/Akt pathway, for the treat..., The Fast Track program of the FDA is designed ...
Breaking Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 1Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 1Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 3Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 4United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 1United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 2
...-Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:...udy of Proellex(TM), an oral drug being developed ...y suggests that,treatment with Proellex results in... symptoms associated with uterine,fibroids and is ...ts , This 12 week, double-blind study compared two...
..., 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc...second multi-center Phase 2 trial of GVAX,immunoth...ng doses,of the immunotherapy in 80 patients with ...C). Additional follow-up of,the 22 patients who re...mployed in the company,s ongoing Phase 3 program i...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: